Exane Derivatives’s Kura Oncology KURA Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2021
Q2 | – | Sell |
-4,606
| Closed | -$130K | – | 1050 |
|
2021
Q1 | $130K | Sell |
4,606
-893
| -16% | -$25.2K | 0.04% | 366 |
|
2020
Q4 | $180K | Sell |
5,499
-2,085
| -27% | -$68.1K | 0.05% | 316 |
|
2020
Q3 | $232K | Buy |
7,584
+275
| +4% | +$8.43K | 0.07% | 185 |
|
2020
Q2 | $119K | Sell |
7,309
-2,396
| -25% | -$39.1K | 0.03% | 256 |
|
2020
Q1 | $96.6K | Buy |
+9,705
| New | +$96.6K | 0.03% | 266 |
|